- Home
- SNGX vs JTAI Comparison
SNGX vs JTAI Comparison
Compare SNGX & JTAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNGX
- JTAI
- Stock Information
- Founded
- SNGX 1987
- JTAI 2018
- Country
- SNGX United States
- JTAI United States
- Employees
- SNGX N/A
- JTAI N/A
- Industry
- SNGX Biotechnology: Pharmaceutical Preparations
- JTAI Blank Checks
- Sector
- SNGX Health Care
- JTAI Finance
- Exchange
- SNGX Nasdaq
- JTAI Nasdaq
- Market Cap
- SNGX 6.5M
- JTAI 9.9M
- IPO Year
- SNGX 1987
- JTAI N/A
- Fundamental
- Price
- SNGX $1.28
- JTAI $3.70
- Analyst Decision
- SNGX
- JTAI
- Analyst Count
- SNGX 0
- JTAI 0
- Target Price
- SNGX N/A
- JTAI N/A
- AVG Volume (30 Days)
- SNGX 2.7M
- JTAI 211.4K
- Earning Date
- SNGX 08-08-2025
- JTAI 08-13-2025
- Dividend Yield
- SNGX N/A
- JTAI N/A
- EPS Growth
- SNGX N/A
- JTAI N/A
- EPS
- SNGX N/A
- JTAI N/A
- Revenue
- SNGX $2,342.00
- JTAI $13,648,668.00
- Revenue This Year
- SNGX N/A
- JTAI $13.37
- Revenue Next Year
- SNGX N/A
- JTAI $201.13
- P/E Ratio
- SNGX N/A
- JTAI N/A
- Revenue Growth
- SNGX N/A
- JTAI N/A
- 52 Week Low
- SNGX $1.09
- JTAI $2.30
- 52 Week High
- SNGX $8.55
- JTAI $97.40
- Technical
- Relative Strength Index (RSI)
- SNGX 34.55
- JTAI 49.53
- Support Level
- SNGX $1.09
- JTAI $3.33
- Resistance Level
- SNGX $1.88
- JTAI $3.75
- Average True Range (ATR)
- SNGX 0.14
- JTAI 0.21
- MACD
- SNGX -0.01
- JTAI 0.03
- Stochastic Oscillator
- SNGX 22.78
- JTAI 59.68
About SNGX Soligenix Inc.
Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely Specialized BioTherapeutics and Public Health Solutions. It generates maximum revenue from Public Health Solutions with active development programs for RiVax, its ricin toxin vaccine candidate, SGX943, its therapeutic candidate for antibiotic resistant and emerging infectious disease, and its research programs to identify and develop novel vaccine candidates targeting viral infection including Ebola, Marburg and SARS-CoV-2 (the cause of COVID-19).
About JTAI Jet.AI Inc.
Jet AI Inc is principally involved in the sale of jet cards, which enable holders to use certain aircraft owned, leased by, arranged, and/or managed by Jet Token and others at agreed-upon rates, as well as the sale of fractional interests in aircraft; and the operation of a proprietary booking platform, which functions as a prospecting and quoting platform to arrange private jet travel with third party carriers as well as via Jet Token's leased and managed aircraft.